| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1048044565 |
| P356 | DOI | 10.1007/S00117-011-2258-Z |
| P698 | PubMed publication ID | 22418973 |
| P2093 | author name string | A Viardot | |
| P2860 | cites work | Genomic aberrations and survival in chronic lymphocytic leukemia | Q28141442 |
| A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project | Q28251216 | ||
| Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's | Q33349465 | ||
| Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial | Q34141305 | ||
| Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas | Q34147803 | ||
| Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial. | Q34156097 | ||
| Prevalence and frequency of circulating t(14;18)-MBR translocation carrying cells in healthy individuals | Q34438365 | ||
| Prevalence of monoclonal gammopathy of undetermined significance | Q34506801 | ||
| Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era | Q34621900 | ||
| Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia | Q34805491 | ||
| Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder(★). | Q34815054 | ||
| Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma | Q36969748 | ||
| Etiologic heterogeneity among non-Hodgkin lymphoma subtypes | Q37003547 | ||
| Understanding and managing ultra high-risk chronic lymphocytic leukemia | Q37829257 | ||
| First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia | Q38380183 | ||
| Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group | Q42957470 | ||
| Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era. | Q43102332 | ||
| CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma | Q43864036 | ||
| V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. | Q44083652 | ||
| Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial | Q44558622 | ||
| Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma | Q44824307 | ||
| High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma | Q48463656 | ||
| Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease. | Q50788116 | ||
| Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q84423954 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 321-329 | |
| P577 | publication date | 2012-04-01 | |
| P1433 | published in | Radiologe | Q15763177 |
| P1476 | title | [Malignant lymphomas: clinical appearance, classification, therapy and prognosis] | |
| P478 | volume | 52 |
Search more.